Scientists at the University of Liverpool have taken another step forward in understanding the bacteria that are causing a devastating Salmonella epidemic currently killing around 400,000 people each year in sub-Saharan Africa.
Published in the journal PLOS Biology and representing five years of work, researchers at the Institute of Integrative Biology have completed one of the largest bacterial comparative gene expression studies to date.
Invasive nontyphoidal Salmonellosis (iNTS) occurs when Salmonella bacteria, which normally cause gastrointestinal illness, enter the bloodstream and spread through the human body. The African iNTS epidemic is caused by a variant of Salmonella Typhimurium (ST313) that is resistant to antibiotics and generally affects individuals with immune systems weakened by malaria or HIV.
"Although the genomes of African and global S. Typhimurium are 95 percent identical, the remaining 5 percent is very different," explains study author Dr. RocÃo Canals Alvarez. "Most of these differences do not cause changes in gene expression, but we need to identify the genetic alterations that affect gene expression and could influence the outcome of a bacterial infection in humans."
To discover these key genetic differences, the researchers carried out a large-scale comparative transcriptomic approach between the lethal African Salmonella and the common 'global' version that causes gastroenteritis.
The researchers grew each of the Salmonella strains in 16 different ways that represented different stages of the human infection process. They also isolated Salmonella from mouse macrophages - immune cells used by the bacteria to hijack the host during infection.
By investigating the transcriptome of African and global S. Typhimurium under these different conditions, they discovered that 677 genes and small RNAs were expressed differently between the two strains.
A parallel proteomic approach identified the gene expression differences that led to alterations at the protein level. Two proof-of-principle experiments revealed the genetic basis of an African Salmonella metabolic defect and discovered a novel bacterial plasmid maintenance system.
To allow researchers all around the world to work with the new information, the new data are presented in a user-friendly online tool called the SalComD23580 gene expression compendium.
"This study takes the power of transcriptomics to a new level for a bacterium. Our 'functional transcriptomic' approach is relevant to a broad audience and can be applied to many other organisms. The analytical pipeline and the community data resource aspects are generic and could inspire others to use a similar approach to answer their research questions," adds professor Jay Hinton, who led the study.
Source: University of Liverpool
The Key to Sterile Processing Success: Leadership Engagement and Team Collaboration
January 24th 2025Effective sterile processing leadership requires active engagement, clear communication, and a transformational approach to foster collaboration, accountability, and quality in infection prevention and surgical instrument management.
Evaluating Automated Dispensing Systems for Disinfectants in Hospitals
January 23rd 2025Hospitals rely on automated disinfectant dispensers, but a study led by Curtis Donskey, MD, found inconsistent dilution levels, with some dispensers releasing only water. Improved monitoring and design modifications are essential.
Alcohol-Based Antiseptics Show Promise for Nasal Decolonization and SSI Prevention
January 23rd 2025A meta-analysis found alcohol-based antiseptics significantly reduce Staphylococcus aureus-related surgical site infections (SSIs), demonstrating efficacy comparable to mupirocin and iodophor, supporting their expanded use in infection prevention strategies.
ASRA Pain Medicine Releases Groundbreaking Infection Control Guidelines for Pain Management
January 22nd 2025The American Society of Regional Anesthesia and Pain Medicine (ASRA Pain Medicine) released comprehensive infection control guidelines for pain procedures, emphasizing prevention, early recognition, multidisciplinary collaboration, and judicious antibiotic use to enhance patient safety and healthcare outcomes.